Product Information
PROCTOZONE-B 10 MG SUPPOSITORY is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.3197 per EA under NDC 57237033703. Its NADAC has been published 50 times since Oct 22, 2025.
The High Outlier badge above means this manufacturer's average price in the Bisacodyl market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237033703
Classification
Generic
Dosage Form
SUPPOSITORY
Route
RECTAL
Effective Date
9/23/2026
Active Ingredients
BISACODYLApproval Type
OTC MONOGRAPH DRUG
FDA Application
M007.60On Market Since
12/1/2024
Pharmacological Classes
Price Statistics
The NADAC for PROCTOZONE-B 10 MG SUPPOSITORY has been published 50 times since Oct 22, 2025, and over the history we have for it it has declined 8.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3197 per EA |
|---|---|
| All-time high | $0.3686 (Jun 10, 2026) |
| All-time low | $0.3197 (Sep 23, 2026) |
| 52-week high | $0.3686 |
| 52-week low | $0.3197 |
| Median price | $0.3479 |
| Average price | $0.3449 |
| Largest weekly change | -7.4% (Aug 19, 2026) |
| Weeks tracked | 50 |
| Tracking since | Oct 22, 2025 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Bisacodyl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Stimulant Laxative class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PROCTOZONE-B 10 MG SUPPOSITORY?
The current National Average Drug Acquisition Cost (NADAC) for PROCTOZONE-B 10 MG SUPPOSITORY, manufactured by Rising Pharma Holdings Inc., is $0.3197 per EA (NDC 57237033703), effective Sep 30, 2026.
How has the price of PROCTOZONE-B 10 MG SUPPOSITORY changed over time?
Over the history we have for it, the NADAC for PROCTOZONE-B 10 MG SUPPOSITORY has declined 8.1%. It has been tracked across 50 weekly CMS publications since Oct 22, 2025.
What are the highest and lowest recorded NADAC prices for PROCTOZONE-B 10 MG SUPPOSITORY?
Since Oct 22, 2025, the NADAC for PROCTOZONE-B 10 MG SUPPOSITORY has ranged from a low of $0.3197 (Sep 23, 2026) to a high of $0.3686 (Jun 10, 2026), with a median of $0.3479 per EA.
Are there cheaper alternatives to PROCTOZONE-B 10 MG SUPPOSITORY?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PROCTOZONE-B 10 MG SUPPOSITORY in a comparable dosage form, but none are currently priced below it.
Who manufactures PROCTOZONE-B 10 MG SUPPOSITORY?
PROCTOZONE-B 10 MG SUPPOSITORY (NDC 57237033703) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.